Impact of Liver Transplantation on Sexual Life and Function
1 other identifier
observational
100
1 country
1
Brief Summary
Liver Transplantation (LT) is a lifesaving intervention with around 90% of recipients currently surviving the first postoperative year and subsequent life expectancy now exceeding 20 years. After the post-operative recovery period, however, LT recipients become more and more confronted with the challenges of re-engagement with life after transplantation, a need to reach a new stability, reestablish function in everyday life, reconnect with valued roles, regain independence, and resume work Sexual function is a very important parameter in the evaluation of Quality of Life (QoL), as it has been shown that sexual dysfunction in transplant patients is associated with increased depression and decreased QoL. There are several studies in the relevant literature supporting the recovery of sexual function in patients after liver transplantation. It has been found that recovery was observed in erectile dysfunction in male patients 6 months after liver transplantation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 22, 2025
CompletedFirst Posted
Study publicly available on registry
December 5, 2025
CompletedStudy Start
First participant enrolled
December 7, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 23, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 23, 2026
December 31, 2025
December 1, 2025
11 months
November 22, 2025
December 24, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Evaluation of sexual function by questionnaire method
Arizona Sexual Experience Scale (ASEX) scores for sexual dysfunction, ASEX scores are 5 point questionnaire with scores given for each question from 1-6. Total scores More than or equal to 19 indicate sexual dysfunction (higher the scores greater the sexual dysfunction).
pre transplant, 3,6,12 months
Evaluation of erectile dysfunction using questionnaire method
International Index for Erectile Function - 5 (IIEF-5) scores for erectile dysfunction IIEF 5 scores are also a 5 point questionnaire with score ranging 0-6 for each question. Total scores less than 15 indicate mild to moderate erectile dusfunction and scores less than 11 indicate moderate erectile dysfunction (lower the scores higher the erectile dysfunction)
pre transplant, 3,6,12 months
Secondary Outcomes (2)
Correlation between testosterone and Meld Na scores
pre transplant, 3,6,12 months
Sarcopenia implication in recovery of sexual function.
pre transplant, 3,6,12 months
Study Arms (1)
Chronic liver Disease
Chronic Liver disease patients undergoing elective liver transplantation
Interventions
Eligibility Criteria
Chronic Liver Disease patients awaiting elective transplantation and post liver transplant patients.
You may qualify if:
- Married male Patients.
- Decompensated Chronic Liver Disease awaiting elective liver transplantation.
- Post Liver Transplant patients with stable graft function.
You may not qualify if:
- Negative consent.
- Patients with ongoing medical and surgical issues (biliary complications, graft complication etc.).
- Acute on Chronic Liver Failure and Acute Liver Failure patients.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
ILBS
New Delhi, National Capital Territory of Delhi, 110070, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Prof. Dr. Viniyendra Pamecha, MS FEBS
ILBS
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 22, 2025
First Posted
December 5, 2025
Study Start
December 7, 2025
Primary Completion (Estimated)
October 23, 2026
Study Completion (Estimated)
October 23, 2026
Last Updated
December 31, 2025
Record last verified: 2025-12